Cargando…

First clinical study using HCV protease inhibitor danoprevir to treat COVID-19 patients

INTRODUCTION: As coronavirus disease 2019 (COVID-19) outbreak globally, repurposing approved drugs is emerging as important therapeutic options. Danoprevir boosted by ritonavir (Ganovo) is a potent hepatitis C virus (HCV) protease (NS3/4A) inhibitor, which was approved and marketed in China since 20...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Hongyi, Zhang, Zhicheng, Wang, Li, Huang, Zhihua, Gong, Fanghua, Li, Xiaodong, Chen, Yahong, Wu, Jinzi J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	4900
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710192/ https://www.ncbi.nlm.nih.gov/pubmed/33235105 http://dx.doi.org/10.1097/MD.0000000000023357

Ejemplares similares

Efficacy and safety of danoprevir plus sofosbuvir in GT 1, 2, 3, or 6 chronic hepatitis C patients with or without cirrhosis in China
por: Pan, Shufang, et al.
Publicado: (2021)

Evaluation of HBV, HCV, and HIV seroprevalence in patients with plasma cell disorders
por: Mert, Duygu, et al.
Publicado: (2020)

Analysis of Hepatitis C Virus Decline during Treatment with the Protease Inhibitor Danoprevir Using a Multiscale Model
por: Rong, Libin, et al.
Publicado: (2013)

Impact of vitamin D receptor and binding protein gene polymorphisms in clinical and laboratory data of HCV patients: Cross sectional study
por: Scalioni, Letícia de Paula, et al.
Publicado: (2018)

Four weeks of paritaprevir/ritonavir/ombitasvir plus dasabuvir encountering dengue fever resulted in sustained virological response in an HCV patient: A case report
por: Huang, Chung-Feng, et al.
Publicado: (2016)

Naturally occurring drug resistance associated variants to hepatitis C virus direct-acting antiviral agents in treatment-naive HCV genotype 1b-infected patients in China
por: Li, Zhanyi, et al.
Publicado: (2017)

In-silico studies of inhibitory compounds against protease enzymes of SARS-CoV-2
por: Khan, Saba, et al.
Publicado: (2023)

Comparison of next-generation sequencing with traditional methods for pathogen detection in cases of lower respiratory tract infection at a community hospital in Eastern China
por: Yang, Yi, et al.
Publicado: (2022)

Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells: A case report
por: Liang, Bing, et al.
Publicado: (2020)

Chest CT of COVID-19 in patients with a negative first RT-PCR test: Comparison with patients with a positive first RT-PCR test
por: Chen, Zu-Hua, et al.
Publicado: (2020)

Malakoplakia and xanthogranulomatous pyelonephritis treated with nephrectomy: A case report
por: Pan, Yueh, et al.
Publicado: (2021)

Prediction of response to sofosbuvir-based therapy using serum interleukin-12 and single nucleotide polymorphism of the interleukin 28B gene as predictive factors in HCV positive genotype-4 patients
por: Mohamed Abdelnajid, Doaa, et al.
Publicado: (2023)

Could lengthening minocycline therapy better treat early syphilis?
por: Shao, Li-Li, et al.
Publicado: (2016)

Luteolin is a potential inhibitor of COVID-19: An in silico analysis
por: Wang, Wenxiang, et al.
Publicado: (2023)

Withdrawing mycophenolate mofetil in treating a young kidney transplant recipient with COVID-19: A case report
por: Chen, Dong, et al.
Publicado: (2020)

Efficacy and Safety of 12-week Interferon-based Danoprevir Regimen in Patients with Genotype 1 Chronic Hepatitis C
por: Wei, Lai, et al.
Publicado: (2019)

Human descending aorta injury caused by brucellosis: A case report
por: Li, Xiao, et al.
Publicado: (2023)

Evaluating the efficacy and safety of bromhexine hydrochloride tablets in treating pediatric COVID-19: A protocol for meta-analysis and systematic review
por: Wang, Yuying, et al.
Publicado: (2020)

A PRISMA-compliant systematic review and meta-analysis of integrated Chinese and Western medicine in treating hepatitis C
por: Li, Xiuqin, et al.
Publicado: (2020)

Danoprevir for the Treatment of Hepatitis C Virus Infection: Design, Development, and Place in Therapy
por: Miao, Miao, et al.
Publicado: (2020)

Clinical Immunophenotype at Disease Onset in Previously Healthy Patients With Cryptococcal Meningitis
por: Xu, Lie, et al.
Publicado: (2016)

Clinical and microbiological characteristics of vancomycin-resistant Enterococcus faecium bloodstream infection in Central Taiwan
por: Chen, Chang-Hua, et al.
Publicado: (2017)

Carbapenems vs tigecycline for the treatment of complicated intra-abdominal infections: A Bayesian network meta-analysis of randomized clinical trials
por: Chen, Lingyuan, et al.
Publicado: (2019)

Efficacy and Safety of All-oral, 12-week Ravidasvir Plus Ritonavir-boosted Danoprevir and Ribavirin in Treatment-naïve Noncirrhotic HCV Genotype 1 Patients: Results from a Phase 2/3 Clinical Trial in China
por: Xu, Xiaoyuan, et al.
Publicado: (2019)

Emergency 1-stage anterior approach for cervical spine infection complicated by epidural abscess
por: Li, Haoxi, et al.
Publicado: (2017)

Spinal epidural abscess successfully treated with biportal endoscopic spinal surgery
por: Kang, Taewook, et al.
Publicado: (2019)

The association between antibiotics and community-associated Staphylococcus aureus colonization in the United States population: Analysis of the National Health and Nutrition Examination Survey (NHANES)
por: Chen, Baixing, et al.
Publicado: (2022)

Effect of a serum lactate monitoring recommendation policy on patients treated with linezolid
por: Im, Jae Hyoung, et al.
Publicado: (2021)

Determinants of serum concentration of first-line anti-tuberculosis drugs from China
por: Lei, Qian, et al.
Publicado: (2019)

Angiotensin-Converting Enzyme Inhibitors and Active Tuberculosis: A Population-Based Study
por: Wu, Jiunn-Yih, et al.
Publicado: (2016)

Rhabdomyolysis in a patient with end-stage renal disease and SARS-CoV-2 infection: A case report
por: Lu, Wenhui, et al.
Publicado: (2023)

Patient-reported Outcomes in Asian Patients With Chronic Hepatitis C Treated With Ledipasvir and Sofosbuvir
por: Younossi, Zobair M., et al.
Publicado: (2016)

Probiotics for treating novel coronavirus with diarrhea: A protocol for systematic review and meta analysis
por: Liu, Min, et al.
Publicado: (2020)

Acute myeloid leukaemia presenting with ecthyma gangrenosum as the first manifestation: A case report
por: Hadano, Yoshiro, et al.
Publicado: (2021)

Novel β-Lactam/β-Lactamase inhibitor combinations vs alternative antibiotics in the treatment of complicated urinary tract infections: A meta-analysis of randomized controlled trials
por: Lu, Li-Chin, et al.
Publicado: (2020)

Coronavirus disease 2019 (COVID-19) related cytopenia: A protocol for systematic review and meta-analysis
por: Li, Yiwei, et al.
Publicado: (2020)

Concomitant lung adenocarcinoma and pulmonary cryptococcosis confirmed by pathologic examinations
por: Huang, Jinbao, et al.
Publicado: (2019)

Prevalence of SARS-CoV-2 amongst ophthalmologists throughout the first and second waves of the pandemic
por: Sacchi, Matteo, et al.
Publicado: (2021)

Prevalence and influencing factors of anxiety and depression symptoms among the first-line medical staff in Wuhan mobile cabin hospital during the COVID-19 epidemic: A cross-sectional survey
por: Zhang, Xiao-Bo, et al.
Publicado: (2021)

Clinical Characteristics and Risk Factor Analysis for Lower-Extremity Amputations in Diabetic Patients With Foot Ulcer Complicated by Necrotizing Fasciitis
por: Chen, I-Wen, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8gt9khcfpmeim2jlmnu0bjnerl